ZNF324B
gene geneOn this page
Also known as FLJ45850
Summary
ZNF324B (zinc finger protein 324B, HGNC:33107) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 324B (Q6AW86). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 388569 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 100 total
- MANE Select transcript:
NM_207395
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33107 |
| Approved symbol | ZNF324B |
| Name | zinc finger protein 324B |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ45850 |
| Ensembl gene | ENSG00000249471 |
| Ensembl biotype | protein_coding |
| Entrez | 388569 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 19 protein_coding
ENST00000336614, ENST00000545523, ENST00000594214, ENST00000598244, ENST00000599193, ENST00000599194, ENST00000869294, ENST00000869295, ENST00000869296, ENST00000869297, ENST00000869298, ENST00000928892, ENST00000928893, ENST00000963232, ENST00000963233, ENST00000963234, ENST00000963235, ENST00000963236, ENST00000963237
RefSeq mRNA: 1 — MANE Select: NM_207395
NM_207395
CCDS: CCDS33138
Canonical transcript exons
ENST00000336614 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001469474 | 58455183 | 58457833 |
| ENSE00001469476 | 58451622 | 58451704 |
| ENSE00003677496 | 58453696 | 58453822 |
| ENSE00003789631 | 58454228 | 58454344 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 81.91.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.2841 / max 48.3036, expressed in 1620 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177846 | 4.2841 | 1620 |
Top tissues by expression
275 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.91 | silver quality |
| cortical plate | UBERON:0005343 | 76.71 | gold quality |
| sural nerve | UBERON:0015488 | 76.30 | gold quality |
| stromal cell of endometrium | CL:0002255 | 74.42 | gold quality |
| ventricular zone | UBERON:0003053 | 73.07 | gold quality |
| prefrontal cortex | UBERON:0000451 | 72.77 | gold quality |
| pancreatic ductal cell | CL:0002079 | 72.43 | silver quality |
| ganglionic eminence | UBERON:0004023 | 72.13 | gold quality |
| gastrocnemius | UBERON:0001388 | 71.72 | gold quality |
| granulocyte | CL:0000094 | 71.58 | gold quality |
| muscle of leg | UBERON:0001383 | 71.12 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 71.06 | gold quality |
| right uterine tube | UBERON:0001302 | 70.72 | gold quality |
| skin of leg | UBERON:0001511 | 70.68 | gold quality |
| endocervix | UBERON:0000458 | 70.48 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.42 | gold quality |
| skin of abdomen | UBERON:0001416 | 70.16 | gold quality |
| leukocyte | CL:0000738 | 70.15 | gold quality |
| right ovary | UBERON:0002118 | 70.02 | gold quality |
| monocyte | CL:0000576 | 70.01 | gold quality |
| mononuclear cell | CL:0000842 | 69.83 | gold quality |
| body of pancreas | UBERON:0001150 | 69.70 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 69.67 | gold quality |
| lower esophagus | UBERON:0013473 | 69.62 | gold quality |
| ectocervix | UBERON:0012249 | 69.41 | gold quality |
| pancreas | UBERON:0001264 | 69.30 | gold quality |
| mucosa of stomach | UBERON:0001199 | 69.24 | gold quality |
| esophagus | UBERON:0001043 | 69.22 | gold quality |
| esophagus mucosa | UBERON:0002469 | 69.15 | gold quality |
| body of stomach | UBERON:0001161 | 69.13 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.55 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
33 targeting ZNF324B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-3667-3P | 99.99 | 67.17 | 1636 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-7110-5P | 99.80 | 67.84 | 1712 |
| HSA-MIR-6842-5P | 99.80 | 67.54 | 1587 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-4753-5P | 99.54 | 68.51 | 1356 |
| HSA-MIR-136-5P | 99.50 | 67.26 | 1153 |
| HSA-MIR-2392 | 99.43 | 67.50 | 708 |
| HSA-MIR-8077 | 99.17 | 66.67 | 862 |
| HSA-MIR-4695-5P | 99.06 | 64.87 | 1151 |
| HSA-MIR-589-5P | 98.72 | 66.96 | 927 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-6852-3P | 98.54 | 67.60 | 1468 |
| HSA-MIR-7114-5P | 98.51 | 67.87 | 1349 |
| HSA-MIR-4684-3P | 98.24 | 69.91 | 1075 |
| HSA-MIR-4717-5P | 98.19 | 67.97 | 894 |
| HSA-MIR-4518 | 98.12 | 66.82 | 1030 |
| HSA-MIR-432-5P | 98.00 | 68.13 | 989 |
| HSA-MIR-6502-3P | 97.86 | 65.43 | 569 |
| HSA-MIR-3664-3P | 97.85 | 67.62 | 1452 |
| HSA-MIR-1266-5P | 97.71 | 66.92 | 1052 |
| HSA-MIR-6859-3P | 97.26 | 64.69 | 428 |
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | 42sp43 | ENSDARG00000104170 |
| mus_musculus | Zfp324 | ENSMUSG00000004500 |
| rattus_norvegicus | Zfp324 | ENSRNOG00000027436 |
| drosophila_melanogaster | dwg | FBGN0000520 |
| drosophila_melanogaster | CG6654 | FBGN0038301 |
| caenorhabditis_elegans | WBGENE00003933 |
Paralogs (6): ZNF324 (ENSG00000083812), ZBTB47 (ENSG00000114853), GTF3A (ENSG00000122034), ZUP1 (ENSG00000153975), ZNF513 (ENSG00000163795), ZNF652 (ENSG00000198740)
Protein
Protein identifiers
Zinc finger protein 324B — Q6AW86 (reviewed: Q6AW86)
All UniProt accessions (5): Q6AW86, M0R090, M0R0B1, M0R1X9, M0R3B5
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q6AW86-1 | 1 | yes |
| Q6AW86-2 | 2 |
RefSeq proteins (1): NP_997278* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (19 total): zinc finger region 9, region of interest 2, sequence conflict 2, chain 1, domain 1, compositionally biased region 1, cross-link 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6AW86-F1 | 64.80 | 0.35 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 214
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 36 (showing top):
PARENT_MTOR_SIGNALING_UP, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, SMAD_Q6, TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP, ATF2_S_UP.V1_UP, ATF2_UP.V1_UP, IL21_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CEBPZ_TARGET_GENES, PCGF1_TARGET_GENES, ZNF669_TARGET_GENES, ZNF768_TARGET_GENES, MIR3202, GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
574 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF324B | EID2 | Q8N6I1 | 635 |
| ZNF324B | RABEP2 | Q9H5N1 | 633 |
| ZNF324B | YIPF4 | Q9BSR8 | 540 |
| ZNF324B | FRMD5 | Q7Z6J6 | 480 |
| ZNF324B | CCDC127 | Q96BQ5 | 445 |
| ZNF324B | ASB7 | Q9H672 | 414 |
| ZNF324B | SUPT7L | O94864 | 409 |
| ZNF324B | CAPN10 | Q9HC96 | 403 |
| ZNF324B | TMC8 | Q8IU68 | 400 |
| ZNF324B | PCMT1 | P22061 | 391 |
| ZNF324B | RPS7 | P23821 | 388 |
| ZNF324B | CNOT10 | Q9H9A5 | 362 |
| ZNF324B | COMMD5 | Q9GZQ3 | 343 |
| ZNF324B | TADA2B | Q86TJ2 | 329 |
| ZNF324B | GJD3 | Q8N144 | 329 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF324B | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF324B | ZNF324 | psi-mi:“MI:0914”(association) | 0.530 |
| KISS1R | ERLIN1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| RGS3 | ZNF646 | psi-mi:“MI:0914”(association) | 0.350 |
| CBX5 | ZNF568 | psi-mi:“MI:0914”(association) | 0.350 |
| NOTCH2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LTBP2 | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| LRP3 | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (150): ZNF324 (Affinity Capture-MS), SPIN3 (Affinity Capture-MS), ACTA1 (Affinity Capture-MS), ZNF324B (Affinity Capture-MS), RBAK (Affinity Capture-MS), TRIM24 (Affinity Capture-MS), SPIN1 (Affinity Capture-MS), NGRN (Affinity Capture-MS), HELZ2 (Affinity Capture-MS), ZNF184 (Affinity Capture-MS), ZNF460 (Affinity Capture-MS), ZNF746 (Affinity Capture-MS), ZNF316 (Affinity Capture-MS), TOPORS (Affinity Capture-MS), RPF1 (Affinity Capture-MS)
ESM2 similar proteins: A3KN32, A6NM28, A8K8V0, E9PYI1, O75467, O95201, P10072, P10075, P10078, P10754, P28698, P30373, P52736, Q0VCC5, Q14929, Q16587, Q17QR7, Q29RZ4, Q3KNW1, Q3TDE8, Q3US17, Q58DK7, Q5RJR4, Q5T619, Q5TEC3, Q5U4E2, Q62396, Q68H95, Q6AW86, Q6PGE4, Q6ZMY9, Q7Z398, Q7Z7K2, Q8BI73, Q8BIF9, Q8BIQ3, Q8BKK5, Q8JZL0, Q8N393, Q8R0T2
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
100 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 87 |
| Likely benign | 12 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1216 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:58453685:T:TA | acceptor_gain | 1.0000 |
| 19:58453688:T:A | acceptor_gain | 1.0000 |
| 19:58453691:TTTAG:T | acceptor_loss | 1.0000 |
| 19:58453694:A:AG | acceptor_gain | 1.0000 |
| 19:58453694:AG:A | acceptor_gain | 1.0000 |
| 19:58453695:G:GA | acceptor_gain | 1.0000 |
| 19:58453695:GG:G | acceptor_gain | 1.0000 |
| 19:58453695:GGA:G | acceptor_gain | 1.0000 |
| 19:58453695:GGAC:G | acceptor_gain | 1.0000 |
| 19:58453695:GGACC:G | acceptor_gain | 1.0000 |
| 19:58453818:ACTTG:A | donor_gain | 1.0000 |
| 19:58453819:CTTG:C | donor_gain | 1.0000 |
| 19:58453823:G:GG | donor_gain | 1.0000 |
| 19:58453824:T:G | donor_loss | 1.0000 |
| 19:58453828:GCCC:G | donor_gain | 1.0000 |
| 19:58454223:CACA:C | acceptor_loss | 1.0000 |
| 19:58454225:CAGG:C | acceptor_loss | 1.0000 |
| 19:58454226:A:AG | acceptor_gain | 1.0000 |
| 19:58454226:A:T | acceptor_loss | 1.0000 |
| 19:58454227:G:GG | acceptor_gain | 1.0000 |
| 19:58454227:GGA:G | acceptor_gain | 1.0000 |
| 19:58454227:GGACT:G | acceptor_gain | 1.0000 |
| 19:58454252:T:TA | acceptor_gain | 1.0000 |
| 19:58454345:G:GG | donor_gain | 1.0000 |
| 19:58454345:G:T | donor_loss | 1.0000 |
| 19:58451655:G:GA | donor_gain | 0.9900 |
| 19:58451702:A:T | donor_gain | 0.9900 |
| 19:58451754:G:GG | donor_gain | 0.9900 |
| 19:58451828:G:GT | donor_gain | 0.9900 |
| 19:58453820:TTG:T | donor_gain | 0.9900 |
AlphaMissense
3552 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:58455824:T:C | F294L | 0.999 |
| 19:58455826:C:A | F294L | 0.999 |
| 19:58455826:C:G | F294L | 0.999 |
| 19:58455908:T:C | F322L | 0.999 |
| 19:58455910:C:A | F322L | 0.999 |
| 19:58455910:C:G | F322L | 0.999 |
| 19:58455992:T:C | F350L | 0.999 |
| 19:58455994:C:A | F350L | 0.999 |
| 19:58455994:C:G | F350L | 0.999 |
| 19:58456076:T:C | F378L | 0.999 |
| 19:58456078:C:A | F378L | 0.999 |
| 19:58456078:C:G | F378L | 0.999 |
| 19:58455740:T:C | F266L | 0.998 |
| 19:58455742:C:A | F266L | 0.998 |
| 19:58455742:C:G | F266L | 0.998 |
| 19:58455759:T:C | L272P | 0.998 |
| 19:58455769:C:A | H275Q | 0.998 |
| 19:58455769:C:G | H275Q | 0.998 |
| 19:58456160:T:C | F406L | 0.998 |
| 19:58456162:C:A | F406L | 0.998 |
| 19:58456162:C:G | F406L | 0.998 |
| 19:58456244:T:C | F434L | 0.998 |
| 19:58456246:T:A | F434L | 0.998 |
| 19:58456246:T:G | F434L | 0.998 |
| 19:58456328:T:C | F462L | 0.998 |
| 19:58456330:C:A | F462L | 0.998 |
| 19:58456330:C:G | F462L | 0.998 |
| 19:58456412:T:C | F490L | 0.998 |
| 19:58456414:C:A | F490L | 0.998 |
| 19:58456414:C:G | F490L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000128585 (19:58418548 C>T), RS1000253189 (19:58420376 A>G), RS1000304254 (19:58435991 T>G), RS1000334350 (19:58419284 G>A,T), RS1000420382 (19:58452022 G>T), RS1000528968 (19:58458115 G>A), RS1000635398 (19:58447892 G>A), RS1000696123 (19:58446127 T>C,G), RS1000726993 (19:58446420 A>G), RS1000786057 (19:58438288 C>T), RS1000796266 (19:58442421 G>A,C,T), RS1000863909 (19:58441361 T>G), RS1000891652 (19:58429962 C>A,T), RS1000960032 (19:58425136 G>C), RS1000975710 (19:58425561 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004599_201 | Mean platelet volume | 1.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
12 total (human), top 12 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| Arsenic | affects methylation | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Calcitriol | decreases expression, affects cotreatment | 1 |
| Estradiol | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.